FSSAI prohibits Dabur from selling food products with '100%' claims

India's food regulator FSSAI has banned Dabur India from selling many products. These products included honey and cow ghee with misleading '100 per cent' claims. The regulator stated these claims were unverifiable and likely to mislead consumers. FSSAI directed Dabur to immediately stop selling these identified food products. An action taken report is required from Dabur within fifteen days.

health.economictimes.indiatimes.com ·2d ago

FSSAI prohibits Dabur from selling food products with '100%' claims

We haven't written up this one. ETHealthworld has the full story — the link below goes straight to it.

Also reported by 1 other outlet

Dabur moves Delhi HC against FSSAI ban on selling food products with '100 pc' claims health.economictimes.indiatimes.com

Read the original at health.economictimes.indiatimes.com →

More in Health & Medicine

One man works to slow the fastest-growing Ebola outbreak in history, and he’s doing it unpaid

BUNIA, Congo (AP) — Wiza Bondele goes to work every day at a hospital in Congo with one goal in mind: to slow the fastest-growing Ebola outbreak on record.

38m ago ·apnews.com

I feel deep sadness about bird flu and environmental loss. Is this normal?

Grief is an understandable response to witnessing harm to places and species that matter to us.

1h ago ·theconversation.com

Dense breasts or breast cancer in the family? What screening changes mean for you

If you are at higher risk of breast cancer, screening looks set to change. Here’s what we know so far.

1h ago ·theconversation.com

What China’s expanded funding for HIV/Aids in Africa means as US cuts health aid

China is expanding its role in the fight against HIV/Aids in Africa by funding new projects and backing local medicine manufacturing as part of its signature health initiative, the Health Silk Road. Beijing’s larger presence comes as traditional Western aid wanes following the closure of the US Agency for International Development and…

2h ago ·scmp.com

What China’s expanded funding for HIV/Aids in Africa means as US cuts health aid

2h ago ·scmp.com

FMT Shows Promise for Peanut Allergy Tolerance in Phase I Trial

A small Phase I trial found that fecal microbiome transplantation (FMT) increased peanut tolerance in some adults with a peanut allergy, while mouse studies suggested the effect may depend on bile acid metabolites.

Phase I trial shows FMT increases peanut reactivity threshold in five participants.
Increased tolerogenic regulatory T cells and decreased type 2 helper T cells linked to tolerance.
Post-FMT microbiomes protect allergy-prone mice from food allergy.

2h ago ·genengnews.com